NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites
NCI 社区肿瘤学研究计划 (NCORP) 少数族裔/服务不足的社区站点
基本信息
- 批准号:10227003
- 负责人:
- 金额:$ 165.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-09 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAddressAdolescentAdvisory CommitteesAftercareAmerican IndiansAsiansAwardAwarenessCancer BurdenCancer CenterCancer Center Support GrantCancer ControlCancer PatientCancer Therapy Evaluation ProgramCatchment AreaChildhoodClinicalClinical TrialsClinical Trials Cooperative GroupClinical Trials NetworkCollaborationsCommunitiesCommunity Clinical Oncology ProgramCommunity HealthCommunity Health SystemsComprehensive Cancer CenterCountyCultural DiversityEnrollmentFoundationsGenomicsGeographyGoalsGrantGrowthHealthHealth InsuranceHealth PersonnelHealth systemHispanic AmericansHispanicsHospitalsImageIncomeInfrastructureInterventionJointsKnowledgeLeadershipLongevityMalignant NeoplasmsMexicanMinority GroupsMissionModelingMolecularNational Clinical Trials NetworkNew MexicoNot Hispanic or LatinoOutcomePatient-Focused OutcomesPatientsPatternPhysiciansPlant RootsPopulationPopulation HeterogeneityPopulation SciencesPovertyPreventionProgram EffectivenessProviderResearchResearch MethodologyRuralRural CommunityRural PopulationScientistScreening for cancerSiteStrategic PlanningSystemTherapeuticTherapeutic Clinical TrialTherapeutic InterventionTherapeutic TrialsUnderserved PopulationUniversitiesWorkbarrier to carebasecancer carecancer clinical trialcancer health disparitycancer preventioncare deliverycare outcomescare providerscaucasian Americancommunity based participatory researchcommunity partnershipcommunity settingdata resourceethnic minority populationgender minorityhealth disparityimprovedinnovationinterestmembermulti-ethnicnext generationoutreach programparticipant enrollmentpatient orientedpreventive interventionprogramsranpirnaserural underservedscreeningsuccesstissue resourcetribal Nationunderserved communityunderserved minorityvirtualworking groupyoung adult
项目摘要
PROJECT SUMMARY/ABSTRACT
The overarching goal of the New Mexico MU-NCORP is to improve the quality of cancer care throughout our
catchment area (the State of New Mexico) and to eliminate the tremendous burden of cancer health disparities
in the multiethnic populations that we serve by building innovative statewide outreach programs, founded in
community-based participatory research methods and scientific collaborations between community health
systems and providers with the primary academic affiliate site, resulting in an increased awareness, acceptance,
access, and participation by all New Mexicans in NCI-sponsored cancer screening, post-treatment surveillance,
prevention, and therapeutic clinical trials. The University of New Mexico Comprehensive Cancer (UNMCCC)
serves as the primary affiliate with strong scientific programs in cancer population sciences, cancer control,
health disparities, and clinical interventions, in partnership with nearly all New Mexico health systems and
community cancer care sites that are consortium members of the New Mexico Cancer Care Alliance (NMCCA,
secondary affiliate), a joint 501c3 statewide clinical trials research network that provides the major clinical trials
infrastructure to support the goals of the NCI NCORP. This NM MU-NCORP organization continues to engage
all stakeholders in our cancer health mission and builds upon a well-established 20 year partnership supported
in part by prior NCI MB-CCOP and current NCORP grants. This consortium has a proven track record and
success in enrolling New Mexico's highly diverse multiethnic, rural, and underserved cancer patients in NCTN
trials and has launched several cancer care delivery (CCDR) trials that are of great interest to our community
partners. The NM MU-NCORP will continue to be actively engaged in developing research strategies across the
NCORP Research Bases and will serve as working partners throughout the NCORP Network. With the highest
percentage of Hispanics and American Indians of any state, New Mexico's 2.1 million citizens are 39% non-
Hispanic White, 47% Hispanic, 10% American Indian, 2.4% Black, and 1.6% Asian and other ethnic minorities.
New Mexico ranks at the bottom (48th) in the U.S. in annual per capita income and a substantial number of New
Mexicans, particularly its minority populations, are poor, rural, and underserved. With the nation's highest rate
(30%) of childhood poverty, nearly 20% of all New Mexicans live in poverty and 10-13% of New Mexicans,
depending on the county, still lack health insurance. Our research strategy is focused on academic/community
team partnerships to address all aspects of cancer screening, prevention, cancer control, cancer care delivery,
and therapeutic intervention in order to prioritize and optimize trial-based cancer care, while enhancing
collaboration with the NCORP Research Bases in order to generate the next generation of trials to address the
cancer disparities of the New Mexicans served by the MU-NCORP.
项目总结/摘要
新墨西哥州MU-NCORP的首要目标是提高我们整个社区的癌症护理质量。
集水区(新墨西哥州)和消除癌症健康差距的巨大负担
在多民族的人口,我们通过建立创新的全州推广计划,成立于
以社区为基础的参与性研究方法和社区卫生之间的科学合作
系统和供应商与主要的学术附属网站,从而提高认识,接受,
所有新墨西哥人都能获得并参与NCI赞助的癌症筛查、治疗后监测,
预防和治疗性临床试验。新墨西哥州综合癌症大学(UNMCCC)
作为癌症人口科学,癌症控制,
健康差距和临床干预措施,与几乎所有新墨西哥州卫生系统合作,
社区癌症护理点是新墨西哥州癌症护理联盟(NMCCA,
二级附属机构),一个联合501 c3全州临床试验研究网络,提供主要的临床试验
基础设施,以支持NCI NCORP的目标。该NM MU-NCORP组织继续参与
所有利益相关者在我们的癌症健康使命,并建立在一个良好的20年的伙伴关系支持
部分由先前的NCI MB-CCOP和当前的NCORP赠款提供。这个财团有着良好的业绩记录,
NCTN成功招募了新墨西哥州高度多样化的多种族、农村和服务不足的癌症患者
试验,并已启动了几个癌症护理交付(CCDR)试验,这是我们的社会极大的兴趣
伙伴NM MU-NCORP将继续积极参与制定跨领域的研究战略。
NCORP研究基地,并将作为整个NCORP网络的工作伙伴。具有最高
任何一个州的西班牙裔和美洲印第安人的百分比,新墨西哥州的210万公民是39%的非
西班牙裔白色,47%西班牙裔,10%美洲印第安人,2.4%黑人,1.6%亚洲人和其他少数民族。
新墨西哥州的人均年收入在美国排名垫底(第48位),
墨西哥人,特别是少数民族,贫穷,农村,服务不足。全国最高的
(30%)的儿童贫困,近20%的新墨西哥人生活在贫困中,10-13%的新墨西哥人,
根据县的情况,仍然缺乏医疗保险。我们的研究策略专注于学术/社区
团队合作,以解决癌症筛查,预防,癌症控制,癌症护理提供,
和治疗干预,以优先考虑和优化基于试验的癌症护理,同时提高
与NCORP研究基地合作,以产生下一代试验,以解决
MU-NCORP所服务的新墨西哥人的癌症差异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CAROLYN Y MULLER其他文献
CAROLYN Y MULLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CAROLYN Y MULLER', 18)}}的其他基金
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites
NCI 社区肿瘤学研究计划 (NCORP) 少数族裔/服务不足的社区站点
- 批准号:
10678911 - 财政年份:2014
- 资助金额:
$ 165.17万 - 项目类别:
NCI Community Oncology Research Program Minority Underserved Community Sites
NCI 社区肿瘤学研究计划少数群体服务不足的社区站点
- 批准号:
8900255 - 财政年份:2014
- 资助金额:
$ 165.17万 - 项目类别:
Phase I Trial of Intraperitoneal Adenoviral p53 Gene Therapy in Ovarian Cancer
腹腔内腺病毒 p53 基因治疗卵巢癌的 I 期试验
- 批准号:
6975048 - 财政年份:2004
- 资助金额:
$ 165.17万 - 项目类别:
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER
I期试验腹腔内腺病毒P53基因治疗——卵巢癌
- 批准号:
6567625 - 财政年份:2001
- 资助金额:
$ 165.17万 - 项目类别:
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER
I期试验腹腔内腺病毒P53基因治疗——卵巢癌
- 批准号:
6414473 - 财政年份:2000
- 资助金额:
$ 165.17万 - 项目类别:
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER
I期试验腹腔内腺病毒P53基因治疗——卵巢癌
- 批准号:
6265031 - 财政年份:1998
- 资助金额:
$ 165.17万 - 项目类别:
相似海外基金
Enhancing Structural Competency in School-Based Health Centers to Address LGBTQ+ Adolescent Health Equity
增强校本健康中心的结构能力,以解决 LGBTQ 青少年健康公平问题
- 批准号:
10608426 - 财政年份:2023
- 资助金额:
$ 165.17万 - 项目类别:
Application and feasability of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care - a pilot study
简短的数字筛查工具的应用和可行性,以解决儿科医疗中父母和青少年烟草和电子烟的使用问题 - 一项试点研究
- 批准号:
486580 - 财政年份:2022
- 资助金额:
$ 165.17万 - 项目类别:
Studentship Programs
Co-design of an intervention to address alcohol use among adolescent boys and young men in Tanzania
共同设计一项干预措施,解决坦桑尼亚青春期男孩和年轻男性的饮酒问题
- 批准号:
MR/V032380/1 - 财政年份:2022
- 资助金额:
$ 165.17万 - 项目类别:
Research Grant
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/1 - 财政年份:2021
- 资助金额:
$ 165.17万 - 项目类别:
Research Grant
Application of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care
应用简短的数字筛查工具来解决儿科医疗中父母和青少年烟草和电子烟的使用问题
- 批准号:
455984 - 财政年份:2021
- 资助金额:
$ 165.17万 - 项目类别:
Operating Grants
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/2 - 财政年份:2021
- 资助金额:
$ 165.17万 - 项目类别:
Research Grant
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
- 批准号:
10057761 - 财政年份:2020
- 资助金额:
$ 165.17万 - 项目类别:
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
- 批准号:
10213683 - 财政年份:2020
- 资助金额:
$ 165.17万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 165.17万 - 项目类别:
Designing targeted interventions to address HIV vulnerabilities and improve clinical outcomes among conflict affected adolescent girls and young women under 25 in Northern Uganda
设计有针对性的干预措施,以解决乌干达北部受冲突影响的少女和 25 岁以下年轻妇女的艾滋病毒脆弱性并改善临床结果
- 批准号:
356145 - 财政年份:2016
- 资助金额:
$ 165.17万 - 项目类别:
Operating Grants














{{item.name}}会员




